Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896257 · ClinicalTrials.gov registry record · NA
De-implementing Inhaled Steroids to Improve Care and Safety in COPD
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
NCT02896257: Completed NA study, sponsored by VA Office of Research and Development.
NCT02896257 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 181 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02896257, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
Study Summary
This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS) for patients with COPD when ICS are not indicated by guidelines.
Interventions
- OTHER Guideline treatment recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2016-09-06 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02896257
The ClinicalTrials.gov registry entry for NCT02896257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guideline treatment recommendations is the first listed.
NCT02896257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02896257 about?
NCT02896257 is a clinical study titled "De-implementing Inhaled Steroids to Improve Care and Safety in COPD". This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS)...
What is the current status of trial NCT02896257?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2016-09-06. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02896257?
The interventions under investigation include: Guideline treatment recommendations (OTHER).
Who is sponsoring clinical trial NCT02896257?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.